ArticlePharmacoEconomics2026

Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: A Cost-Effectiveness Analysis.

Daniel Evans et al.PubMed ↗Publisher ↗

No numbers read from the abstract.